🔗 Permalink

Inventor profile of:

Saul YEDGAR

City:

Jerusalem

Country:

Israel

Published Applications:

Last publication date:

2024-05-23

Top Assignees for applications by Saul YEDGAR

The entities that hold a legal rights for patent applications filed by inventor YEDGAR Saul:

YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM 15 Jerusalem, Israel
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, LTD. 10 Jerusalem, Israel
YISSUM RESEARCH DEVELOPMENT COMPANY 5 Jerusalem, Israel
COLUMBIA UNIVERSITY 1 New York, NY United States
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. 1 , Israel
Yissum Research Development Company of the Hebrew Unitersity of Jerusalem 1 Jerusalem, Israel
YISSUM RESEARCH DEVELOPMENT COMPANY 1 Givat-Ram, Israel

Recent patent applications by YEDGAR Saul

Saul YEDGAR from Jerusalem, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-05-23

US20240165148A1

Human necessities

HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES

#2 | 2021-11-04

US20210338582A1

Human necessities

Liposomes comprising polymer-conjugated lipids and related uses

#3 | 2020-08-06

US20200246265A1

Human necessities

LIPOSOMES COMPRISING POLYMER-CONJUGATED LIPIDS AND RELATED USES

#4 | 2020-04-16

US20200113495A1

Human necessities

System and method for non-invasive monitoring of blood conditions

#5 | 2019-05-16

US20190142751A1

Human necessities

Liposomes comprising polymer-conjugated lipids and related uses

#6 | 2015-04-30

US20150119567A1

Human necessities

Lipid-polymer conjugates, their preparation and uses thereof

#7 | 2015-02-26

US20150057245A1

Human necessities

USE OF LIPID CONJUGATES IN THE TREATMENT OF INFLAMMATORY DISORDERS

#8 | 2015-02-26

US20150057244A1

Human necessities

USE OF LIPID CONJUGATES IN THE TREATMENT OF DISEASE

#9 | 2015-01-22

US20150025233A1

Chemistry; metallurgy

USE OF LIPID CONJUGATES IN THE TREATMENT OF DISEASES

#10 | 2014-10-30

US20140323434A1

Human necessities

LIPID CONJUGATES IN THE TREATMENT OF CHRONIC RFHINOSINUSITIS

#11 | 2014-07-17

US20140199241A1

Human necessities

Liposomes comprising polymer-conjugated lipids and related uses

#12 | 2014-04-10

US20140100190A1

Human necessities

USE OF LIPID CONJUGATES IN CYSTIC FIBROSIS AND APPLICATIONS THEREOF

#13 | 2014-01-02

US20140005115A1

Human necessities

LIPID CONJUGATES IN THE TREATMENT OF BRONCHITIS

#14 | 2013-12-19

US20130338058A1

Human necessities

Use of lipid conjugates in the treatment of conjunctivitis

#15 | 2013-11-28

US20130316973A1

Human necessities

USE OF LIPID CONJUGATES IN THE TREATMENT OF CANCER

#16 | 2013-08-08

US20130203979A1

Chemistry; metallurgy

Use of lipid conjugates in the treatment of diseases

#17 | 2012-04-05

US20120083466A1

Human necessities

Lipid conjugates in the treatment of allergic rhinitis

#18 | 2012-03-22

US20120071442A1

Human necessities

Lipid conjugates in the treatment of chronic rhinosinusitis

#19 | 2011-09-22

US20110230652A1

Chemistry; metallurgy

Use of lipid conjugates in the treatment of diseases

#20 | 2011-06-02

US20110130555A1

Human necessities

LIPID-POLYMER CONJUGATES, THEIR PREPARATION AND USES THEREOF

#21 | 2010-12-16

US20100317591A1

Human necessities

Use of lipid conjugates in the treatment of diseases

#22 | 2010-04-08

US20100087397A1

Human necessities

Use of lipid conjugates in the treatment of conjunctivitis

#23 | 2010-01-28

US20100022473A1

Human necessities

Use of lipid conjugates in the treatment of diseases associated with vasculature

#24 | 2009-12-31

US20090325876A1

Human necessities

USE OF LIPID CONJUGATES IN THE TREATMENT OF DISEASES ASSOCIATED WITH VASCULATURE

#25 | 2008-11-27

US20080293672A1

Human necessities

Lipid conjugates in the treatment of disease

#26 | 2008-08-14

US20080194806A1

Chemistry; metallurgy

Use of lipid conjugates in the treatment of diseases

#27 | 2008-07-31

US20080183282A1

Human necessities

Use of lipid conjugates for the coating of stents and catheters

#28 | 2008-05-15

US20080113935A1

Human necessities

Use of lipid conjugates in the treatment of diseases or disorders of the eye

#29 | 2008-05-15

US20080113002A1

Human necessities

Contact lens compositions

#30 | 2007-08-09

US20070185052A1

Human necessities

Use of lipid conjugates in cystic fibrosis and applications thereof

#31 | 2007-07-05

US20070155700A1

Human necessities

Use of lipid conjugates in the treatment of conjunctivitis

#32 | 2007-05-24

US20070117779A1

Human necessities

Use of lipid conjugates in the treatment of disease

#33 | 2007-04-05

US20070078107A1

Human necessities

Use of lipid conjugates in the treatment of disease

#34 | 2006-12-28

US20060293276A1

Human necessities

Use of lipid conjugates in the treatment of disease

#35 | 2006-11-28

US10790182

Use of lipid conjugates in the treatment of diseases

#36 | 2006-09-05

US10627981

Use of lipid conjugates in the treatment of diseases

#37 | 2006-08-24

US20060189571A1

Human necessities

Use of lipid conjugates in the treatment of infection

#38 | 2006-08-24

US20060189570A1

Human necessities

Use of lipid conjugates in the treatment of infection

#39 | 2006-08-24

US20060189569A1

Human necessities

Use of lipid conjugates in the treatment of infection

#40 | 2006-08-24

US20060189568A1

Human necessities

Use of lipid conjugates in the treatment of infection

#41 | 2006-04-25

US9756765

Use of lipid conjugates in the treatment of disease

#42 | 2006-04-13

US20060079485A1

Human necessities

Use of lipid conjugates in the treatment of infection

#43 | 2005-11-03

US20050245464A1

Human necessities

Use of lipid conjugates in the treatment of diseases

#44 | 2005-09-15

US20050203054A1

Human necessities

Use of lipid conjugates in the treatment of diseases

#45 | 2005-06-30

US20050143288A1

Human necessities

Use of lipid conjugates in the treatment of diseases

#46 | 2005-04-14

US20050079211A1

Human necessities

Use of lipid conjugates in the treatment of diseases of the nervous system

InventorID:

379093 ⎘